Ms Shanwanda Sims, in Amite, LA - Licensed Vocational Nurse

Ms Shanwanda Sims, is a Licensed Vocational Nurse based in Amite, Louisiana. Ms Shanwanda Sims is licensed to practice in Louisiana (license number 220394) and her current practice location is 11236 Highway 16, Amite, Louisiana. She can be reached at her office (for appointments etc.) via phone at (985) 748-2220.

NPI number for Ms Shanwanda Sims is 1417392051 and her current mailing address is Po Box 716, Natalbany, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1417392051.

Contact Information

	Ms Shanwanda Sims,
	11236 Highway 16, Amite, LA 70422-4146
	(985) 748-2220
	Not Available

Provider's Profile

Full Name	Ms Shanwanda Sims
Gender	Female
Speciality	Licensed Vocational Nurse
Location	11236 Highway 16, Amite, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1417392051
Provider Enumeration Date: 05/09/2013
Last Update Date: 05/09/2013

Medical Identifiers

Medical identifiers for Ms Shanwanda Sims such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417392051	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	220394 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Shanwanda Sims is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Shanwanda Sims, Po Box 716, Natalbany, LA 70451-0716 Ph: (985) 474-9025	Ms Shanwanda Sims, 11236 Highway 16, Amite, LA 70422-4146 Ph: (985) 748-2220

News Archive

Kensey Nash announces financial results for fourth-quarter and full fiscal year 2009

Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2009.

Proactive health measures are the secret to health and happiness

The secret to health and happiness just may lie in the simple things, like spending time outdoors, according to a new survey by Traditional Medicinals, the nation's leading wellness tea company.

Three GOP Senators offer alternative plan to replace Obamacare

The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.

Ms Shanwanda Sims, - Licensed Vocational Nurse in Amite, LA